Bupropion for fatigue and as a tumor necrosis factor-α lowering agent in primary biliary cirrhosis
✍ Scribed by Eric Lewin Altschuler; Richard E. Kast
- Book ID
- 116742039
- Publisher
- Elsevier Science
- Year
- 2005
- Tongue
- English
- Weight
- 134 KB
- Volume
- 64
- Category
- Article
- ISSN
- 0306-9877
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## Objective Patients with rheumatoid arthritis (RA) who experience treatment failure with one anti–tumor necrosis factor (anti‐TNF) agent, due to either inefficacy or toxicity, are frequently switched to a second anti‐TNF agent, although the benefits of switching are unknown. The pres
Common genetic variants significantly influence complex diseases such as primary biliary cirrhosis (PBC). We recently reported an association between PBC and a single nucleotide polymorphism (rs231725) of the immunoreceptor gene cytotoxic T-lymphocyte antigen 4 (CTLA4). We hypothesized that PBC risk
## membrane barrier function in the late phase. (HEPATOL-Kupffer cells have been implicated in playing an im- OGY 1996;24:1185-1192.) portant role in the pathogenesis of endotoxemia-associated liver injury. The present study was designed to investigate whether Kupffer cell-derived mediators alter